When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Ozempic is under clinical development by Novo Nordisk and currently in Phase III for Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD).

Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.

Following rapid (and pricey) expansion efforts from Novo and Lilly, plus recent shortage updates at the FDA, “positive ...

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

As weight-loss drugs have exploded in popularity this past year, part of the craze has been members of the public wondering which celebrities are on Ozempic.

In recent developments, health officials in Europe have launched an investigation into the popular weight loss drug Ozempic, ...

Ozempic has become a popular wonder drug among many Hollywood celebrities, who turned to the diabetes medication to lose ...

Learn how the power of dividend growth investing and how commitment and a long-term mindset can help you reach your financial ...

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications. More than an estimated million Floridians are now using weight-loss medications, and experts ...

Musk has been a vocal fan of weight-loss drugs. Say goodbye to cookies and candy canes. This holiday season, Elon Musk is calling himself “Ozempic Santa.” Adorned in a Santa suit in a photo ...

From weight-loss drugs to nonopioid pain killers to AI, here are some important -- and positive -- trends in health care.